Table 3—

Characteristics independently associated with quality of life before and 1 year after screening for diabetes.

CharacteristicBaseline PCSFollow-up PCSBaseline MCSFollow-up MCS
Demographics
 Age (10-year increase)1.5 (0.3, 2.6)*0.3 (−0.5, 1.1)5.1 (3.7, 6.5)*2.0 (0.9, 3.0)*
 Non-white race1.3 (−2.7, 0.1)0.9 (−1.9, 0.1)0.2 (−1.9, 1.4)−0.1 (−1.1, 1.3)
 Female sex2.1 (−0.7, 4.8)0.5 (−1.4, 2.5)1.7 (−1.7, 5.0)1.7 (−0.7, 4.0)
Comorbidity
 No comorbidityReferenceReferenceReferenceReference
 Mild comorbidity−11.6 (−14.6, −8.5)*−3.8 (−6.0, −1.6)*−0.3 (−4.1, 3.3)−1.2 (−3.8, 1.4)
 Moderate comorbidity−13.1 (−16.4, −9.8)*−4.3 (−6.6, −1.9)*−0.3 (−4.3, 3.6)−0.6 (−3.4, 2.2)
 Severe comorbidity−15.2 (−18.7, −11.7)*−4.4 (−6.9, −1.9)*−3.1 (−7.2, 1.1)−1.2 (−4.2, 1.7)
Exercise level6.7 (5.4, 8.0)*−0.6 (−2.8, 1.6)5.7 (4.2, 7.2)*1.5 (0.4, 2.6)*
Quality of life, affect
 Baseline PCSNA0.70 (0.66, 0.74)*Not includedNot included
 Baseline MCSNot includedNot includedNA0.75 (0.71, 0.79)*
Screened (+) for diabetes0.4 (−2.6, 3.5)−0.1 (−2.1, 2.0)0.5 (−4.2, 3.1)−0.4 (−2.9, 2.2)
  • Data are regression parameter estimates for association with PCS or MCS, with 95% CIs for that parameter estimate in parentheses.

  • *

    * P < 0.05